Bioworld Financial Watch articles from March 2007

Bioworld Financial Watch archives from March 2007

Glufosfamide down, not out; Threshold sifts Phase III data.(Threshold Pharmaceuticals Inc.)
March 5, 2007... Glufosfamide's Phase III fizzle in second-line pancreatic cancer pared away almost 60 percent of Threshold Pharmaceuticals Inc.'s value last week and put a dent in hopes raised by Phase II data in late December, but the compound can't be...

Public financing of biotechnology: February 2007.(Statistical data)
March 5, 2007... I. COMMENCED TRADING IN FEBRUARY Shares Company Date Date Shares/ Out (Symbol) (#) Filed Comm. Units (M) Price (M)...

Other financings of public biotechnology companies: February 2007.(Statistical table)
March 5, 2007... TOTAL: $1,334.32M Number Of Shares, Units Company Type Of Or Warrants (Symbol) (#) Financing (M) Amount Raised (M) ...

Venture capital and other investments in private biotechnology companies: February 2007.(Statistical table)
March 5, 2007... FINANCING OF PRIVIATE BIOTECHNOLOGY COMPANIES: $763.5M Company Location Date Amt. (M) Advanced La Jolla, Calif. 2/28 $25.5 BioHealing Inc. AlphaVax Inc. Research...

Milestone payments from corporate partners: February 2007.(Table)
March 5, 2007... TOTAL: $55.26M Year to Date: $84.16M Company Partner (Symbol) (#*) (Country) Amt. (M) Triggering Event Acorda Paul Capital $5 Milestone payment Therapeutics Healthcare...

Money raised by biotech in 2007: January-February.(Brief article)(Statistical data)
March 5, 2007... These graphs compare the performance of the biotech stocks for all of 2007 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 302 U.S. biotech and biotech-related stocks that...

BioWorld stock report for public biotechnology companies.(Statistical table)
March 5, 2007... Close Close %Change Vol Company Symbol 2/23 3/2 WK YTD (000) Aastrom Biosci ASTM 1.5 1.39 -7.33 13.01 3492 Acadia Pharma ACAD 7.84...

With two Phase III therapies, HGS still tricky bet to make.
March 12, 2007... Investors cheered over Human Genome Sciences Inc.'s Phase IIb news about two weeks ago that Albuferon worked when given at 900-mcg doses every two weeks with ribavarin to genotype 1, chronic hepatitis C virus patients--but not everybody is...

Clinical trials update: February 2007.(Table)
March 12, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE Abbott Humira (FDA- Adalimumab; fully human antibody Laboratories approved) designed to block TNF-alpha (NYSE:ABT) BioMS...

Non-U.S. clinical trials and regulatory actions: February 2007.(Table)
March 12, 2007... Company* (Country; Symbol) Product Description CANCER BioCryst Fodosine A transition-state analog inhibitor of Pharmaceuticals purine nucleoside phosphorylase Inc. (BCRX)...

FDA submissions, approvals and other actions: February 2007.(Table)
March 12, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE Abbott Humira Adalimumab; fully human Laboratories (FDA-approved) antibody designed to block TNF-alpha (NYSE:ABT) CANCER...

BioWorld stock report for public biotechnology companies.(Statistical table)
March 12, 2007... Close Close %Change Vol Company Symbol 3/2 3/9 WK YTD (000) Aastrom Biosci ASTM 1.39 1.38 -0.72 12.20 3040 Acadia Pharma ACAD 6.94...

Survey results could boost Pharmion's lung cancer drug.(Poniard's Picoplatin A Wild Card)
March 19, 2007... At the start of the month, Pharmion Corp. said the European Medicines Agency accepted for review its application for Thalidomide Pharmion, its therapy for untreated multiple myeloma that was licensed from Celgene Corp. (which markets the...

Collaborations between biotechnology companies and government/nonprofit institutions: Nov. 29, 2006-March 14, 2007.
March 19, 2007... Company* University/ (Country; Symbol) Nonprofit (@) Type Of Agreement Acacia Research The Centre for Partnership Corp. (ACTG) Applied Genomics (Canada) Advanced Cell ...

BioWorld stock report for public biotechnology companies.(Statistical table)
March 19, 2007... Close Close %Change Vol Company Symbol 3/9 3/16 WK YTD (000) Aastrom Biosci ASTM 1.38 1.34 -2.90 8.94 2070 Acadia Pharma ACAD 6.76...